Skip to main content
Overview
Events & Presentations
Stock Info
Stock Quote
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEC Filings
Governance
Governance Documents
State Disclosures
Board of Directors
Committee Composition
Resources
Investor Email Alerts
Contact Us
Event Details
BridgeBio Pharma shares topline 30-month results from Phase 3 ATTRibute-CM study
July 17, 2023 8:00 AM EDT
Webcast
(opens in new window)